| Trial Identifier: | D7260C00011 |
| Sponsor: | AstraZeneca |
| Collaborator: |
Fortrea Clinical Research Unit Inc.
|
| Start Date: | December 2024 |
| Primary Completion Date: | October 2025 |
| Study Completion Date: | October 2025 |
| Condition: | Liver, Pancreas & Gallbladder - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| US, CA | Lake Forest, CA, US, 92630 |
| US, CA | Rialto, CA, US, 92377 |
| US, FL | Orlando, FL, US, 32809 |
| US, TX | San Antonio, TX, US, 78215 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company